Home
Marksans Pharma Limited
Press Release Jun 19 2025
Business
Jun 19 2025
3 min read

Press Release Jun 19 2025

Marksans Pharma Limited has informed the Exchange regarding a press release dated Jun 19, 2025, titled "Marksans Pharma Limited s wholly owned subsidiary in the UK, Relonchem Limited receives Marketing Authorization for the product Oxybutynin hydrochloride 2.5mg/5ml Oral Solution.".

View Attachment

Original text
Rate this translation
Your feedback will be used to help improve Google Translate